New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies

Recruiting now

Conditions studied: BK Virus Infection

In brief

BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.

Key facts

Study ID

NCT05264259

Run by

University Hospital, Strasbourg, France

People needed

100

Starts

2022-09-05

Expected to finish

2025-12-01

Last updated by the study team

2025-08-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BK positive
• adult
• ok to participed to research

You may not qualify if…

• under guardianship
• under curatorship
• opposed to research
• deprived of liberty

Where it is running

• Service de Virologie - CHU Strasbourg - France — Strasbourg, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.